# A Phase 1/2, Open-Label, Single and Multiple Ascending Dose Study of CRMA-1001 in Adults With Chronic Hepatitis B

> **NCT07200193** · PHASE1,PHASE2 · RECRUITING · sponsor: **nChroma Bio** · enrollment: 66 (estimated)

## Conditions studied

- Chronic Hepaititis B

## Interventions

- **GENETIC:** CRMA-1001

## Key facts

- **NCT ID:** NCT07200193
- **Lead sponsor:** nChroma Bio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-22
- **Primary completion:** 2032-12-31
- **Final completion:** 2032-12-31
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2026-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07200193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07200193, "A Phase 1/2, Open-Label, Single and Multiple Ascending Dose Study of CRMA-1001 in Adults With Chronic Hepatitis B". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07200193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*